rs138161478

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000356239.8(AKAP9):​c.1099G>A​(p.Val367Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000372 in 1,565,676 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V367V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 1 hom. )

Consequence

AKAP9
ENST00000356239.8 missense

Scores

1
17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:2B:6

Conservation

PhyloP100: -0.108
Variant links:
Genes affected
AKAP9 (HGNC:379): (A-kinase anchoring protein 9) The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008812994).
BP6
Variant 7-92001016-G-A is Benign according to our data. Variant chr7-92001016-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 180260.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-92001016-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AKAP9NM_005751.5 linkuse as main transcriptc.1099G>A p.Val367Met missense_variant 8/50 ENST00000356239.8 NP_005742.4
AKAP9NM_147185.3 linkuse as main transcriptc.1099G>A p.Val367Met missense_variant 8/50 NP_671714.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AKAP9ENST00000356239.8 linkuse as main transcriptc.1099G>A p.Val367Met missense_variant 8/501 NM_005751.5 ENSP00000348573 P4Q99996-2

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
152116
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000427
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000346
AC:
63
AN:
182088
Hom.:
0
AF XY:
0.000330
AC XY:
32
AN XY:
97018
show subpopulations
Gnomad AFR exome
AF:
0.0000927
Gnomad AMR exome
AF:
0.0000381
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000337
Gnomad FIN exome
AF:
0.00127
Gnomad NFE exome
AF:
0.000367
Gnomad OTH exome
AF:
0.000203
GnomAD4 exome
AF:
0.000379
AC:
536
AN:
1413442
Hom.:
1
Cov.:
31
AF XY:
0.000339
AC XY:
237
AN XY:
698928
show subpopulations
Gnomad4 AFR exome
AF:
0.0000318
Gnomad4 AMR exome
AF:
0.0000273
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000290
Gnomad4 FIN exome
AF:
0.000860
Gnomad4 NFE exome
AF:
0.000414
Gnomad4 OTH exome
AF:
0.000273
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
152234
Hom.:
0
Cov.:
33
AF XY:
0.000309
AC XY:
23
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.0000962
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000945
Gnomad4 NFE
AF:
0.000427
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.000277
Hom.:
0
Bravo
AF:
0.000204
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000254
AC:
30

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Long QT syndrome 2 Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingBlueprint GeneticsMay 26, 2014- -
Cardiac arrest Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingBlueprint GeneticsMay 26, 2014- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxAug 23, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 13, 2023- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 28, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.7
DANN
Benign
0.48
DEOGEN2
Benign
0.28
.;.;T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.83
T;T;T;T
M_CAP
Benign
0.0068
T
MetaRNN
Benign
0.0088
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.62
N;.;.;.
REVEL
Benign
0.055
Sift
Uncertain
0.019
D;.;.;.
Sift4G
Benign
0.20
.;T;T;.
Vest4
0.072
MVP
0.21
MPC
0.059
ClinPred
0.0024
T
GERP RS
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.029
gMVP
0.072

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138161478; hg19: chr7-91630330; API